Radioimmunotherapy for NHL: experience of 90Y-Ibritumomab Tiuxetan in clinical practice

Translated title of the contribution: Radioimmunotherapy for NHL: experience of 90Y-Ibritumomab Tiuxetan in clinical practice

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Radioimmunotherapy for NHL: experience of 90Y-Ibritumomab Tiuxetan in clinical practice
Original language	Undefined/Unknown
Pages (from-to)	S37-S47
Number of pages	11
Journal	Leukemia and Lymphoma
Volume	44
Publication status	Published - 2003

Cite this

@article{4fb502c799124429b7bdcc34baea9e9a,

title = "Radioimmunotherapy for NHL: experience of 90Y-Ibritumomab Tiuxetan in clinical practice",

author = "A. Hagenbeek",

year = "2003",

language = "Undefined/Unknown",

volume = "44",

pages = "S37--S47",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor and Francis Ltd.",

}